Pascale Witz currently serves as founder and president of PWH Advisors, providing consulting and advisory services to life sciences companies and investors. From 2013 to 2016, Ms. Witz served at Sanofi SA in a number of senior executive roles, including as executive vice president, global diabetes and cardiovascular. Prior to joining Sanofi, Ms. Witz served more than 17 years at GE Healthcare, including as president and chief executive officer of its medical diagnostics business. Ms. Witz serves on the board of directors for PerkinElmer, Inc. (NYSE: PKI), Horizon Pharma Plc (NASDAQ: HZNP), Regulus Therapeutics, Inc. (NASDAQ: RGLS), Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) and Savencia SA (Euronext Paris: SAVE.PA). Ms. Witz plans to cease serving on the board of Savencia prior to the Annual Meeting. Ms. Witz earned her Master of Business Administration in 15 Table of Contents Economics and Marketing from INSEAD and her Master of Science in Biochemistry from INSA Lyon. The board of directors believes Ms. Witz's years of experience in the pharmaceutical and healthcare industry as both a senior executive and board member provide her with the qualifications and skills to serve as a director.
Our Board is driven by sound corporate governance.